BORAY.US Bora Pharmaceuticals Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
2.49 USD
Close of Nov 14, 2026
2.21 7.00
Market cap
USD 318M
P/E
5.4x
P/B
0.69x
ROE
7.7%
Dividend yield
2.53%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BORAY.US undervalued?

Graham number
Price2.49
Graham value6.10
Discount59.2%

BORAY.US trades 59.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bora Pharmaceuticals Co., Ltd. fundamental analysis

No fundamental analysis for Bora Pharmaceuticals Co., Ltd. yet.

Bora Pharmaceuticals Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bora Pharmaceuticals Co., Ltd.

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western p…

Full company profile